Chemokine receptor CCR5 in interferon-treated multiple sclerosis

F Sellebjerg; T B Kristiansen; P Wittenhagen; P Garred; J Eugen-Olsen; Jette L. Frederiksen; Torben Lykke Sørensen

doi:10.1111/j.1600-0404.2007.00826.x

Chemokine receptor CCR5 in interferon-treated multiple sclerosis

F Sellebjerg, T B Kristiansen, P Wittenhagen, P Garred, J Eugen-Olsen, Jette L. Frederiksen, Torben Lykke Sørensen

Department of Clinical Medicine

14 Citations (Scopus)

Abstract

To study the relationship between CC chemokine receptor CCR5 expression and disease activity in multiple sclerosis (MS) patients treated with beta-interferon (IFN-beta).

Original language	English
Journal	Acta Neurologica Scandinavica
Volume	115
Issue number	6
Pages (from-to)	413-8
Number of pages	6
ISSN	0001-6314
DOIs	https://doi.org/10.1111/j.1600-0404.2007.00826.x
Publication status	Published - Jun 2007

Keywords

Adult
Biological Markers
Central Nervous System
DNA Mutational Analysis
Female
Gene Frequency
Genetic Markers
Genetic Predisposition to Disease
Genetic Testing
Genotype
Humans
Interferon-beta
Interferons
Male
Middle Aged
Monocytes
Multiple Sclerosis, Relapsing-Remitting
Mutation
Polymorphism, Genetic
Promoter Regions, Genetic
Receptors, CCR5

Access to Document

10.1111/j.1600-0404.2007.00826.x

Cite this

@article{ea87541be9114fada94f5718850b0f7f,

title = "Chemokine receptor CCR5 in interferon-treated multiple sclerosis",

abstract = "To study the relationship between CC chemokine receptor CCR5 expression and disease activity in multiple sclerosis (MS) patients treated with beta-interferon (IFN-beta).",

keywords = "Adult, Biological Markers, Central Nervous System, DNA Mutational Analysis, Female, Gene Frequency, Genetic Markers, Genetic Predisposition to Disease, Genetic Testing, Genotype, Humans, Interferon-beta, Interferons, Male, Middle Aged, Monocytes, Multiple Sclerosis, Relapsing-Remitting, Mutation, Polymorphism, Genetic, Promoter Regions, Genetic, Receptors, CCR5",

author = "F Sellebjerg and Kristiansen, {T B} and P Wittenhagen and P Garred and J Eugen-Olsen and Frederiksen, {Jette L.} and S{\o}rensen, {Torben Lykke}",

year = "2007",

month = jun,

doi = "10.1111/j.1600-0404.2007.00826.x",

language = "English",

volume = "115",

pages = "413--8",

journal = "Acta Neurologica Scandinavica",

issn = "0001-6314",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Chemokine receptor CCR5 in interferon-treated multiple sclerosis

AU - Sellebjerg, F

AU - Kristiansen, T B

AU - Wittenhagen, P

AU - Garred, P

AU - Eugen-Olsen, J

AU - Frederiksen, Jette L.

AU - Sørensen, Torben Lykke

PY - 2007/6

Y1 - 2007/6

N2 - To study the relationship between CC chemokine receptor CCR5 expression and disease activity in multiple sclerosis (MS) patients treated with beta-interferon (IFN-beta).

AB - To study the relationship between CC chemokine receptor CCR5 expression and disease activity in multiple sclerosis (MS) patients treated with beta-interferon (IFN-beta).

KW - Adult

KW - Biological Markers

KW - Central Nervous System

KW - DNA Mutational Analysis

KW - Female

KW - Gene Frequency

KW - Genetic Markers

KW - Genetic Predisposition to Disease

KW - Genetic Testing

KW - Genotype

KW - Humans

KW - Interferon-beta

KW - Interferons

KW - Male

KW - Middle Aged

KW - Monocytes

KW - Multiple Sclerosis, Relapsing-Remitting

KW - Mutation

KW - Polymorphism, Genetic

KW - Promoter Regions, Genetic

KW - Receptors, CCR5

U2 - 10.1111/j.1600-0404.2007.00826.x

DO - 10.1111/j.1600-0404.2007.00826.x

M3 - Journal article

C2 - 17511851

SN - 0001-6314

VL - 115

SP - 413

EP - 418

JO - Acta Neurologica Scandinavica

JF - Acta Neurologica Scandinavica

IS - 6

ER -

Chemokine receptor CCR5 in interferon-treated multiple sclerosis

Abstract

Keywords

Access to Document

Fingerprint

Cite this